Conventional therapies in this indication include corticosteroids, immunomodulators and primary nutrition therapy. The approval follows a positive opinion granted in March by the Committee for Medicinal Products for
The settlement, which is covered in its entirety by Pharmos’ insurance, has been reached with no admission of liability by any party, the New Jersey-based company said. Pharmos
Commenting on the ruling, Robert Armitage, Lilly’s senior vice president and general counsel said: “These decisions, if not overturned, undermine intellectual property protection in Canada and Germany and
The designation applies to the use of Tamibarotene in patients with relapsed or refractory acute promyelocytic leukemia (APL) following treatment with all-trans retinoic acid (ATRA) and arsenic trioxide.
The drug, MK-0974, was generally well tolerated in the study. Responses specific to other measures, such as migraine-associated symptoms, functional disability and use of additional rescue medications also
The Lyon plant will replace Genzyme’s smaller plant in nearby Marcy l’Etoile and will provide more than twice the manufacturing capacity. Construction is expected to begin later this
Mucosal IgA antibodies are considered as a possible first line of defense against infection by HIV, according to Mymetics. The results demonstrated that more than 90% of non-human
Male hypogonadism is an increasingly recognized medical condition characterized by a reduced or absent secretion of testosterone from the testes. Reduced testosterone levels can lead to health problems
The randomized, double-blind study will compare the efficacy and safety of Labopharm’s once-daily formulation of trazodone to placebo in patients with major unipolar depressive disorder. The trial, which
The payment was triggered by completion of the licensing agreement following regulatory clearance from US authorities, the company said. The drug, ASA404 is a small-molecule vascular disrupting agent
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.